XK
SGMO

Xact Kapitalforvaltning’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Xact Kapitalforvaltning’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$111K Hold
17,446
– – ﹤0.01% 1280
2019
Q4 		$146K Hold
17,446
– – ﹤0.01% 1397
2019
Q3 		$158K Hold
17,446
– – ﹤0.01% 1396
2019
Q2 		$188K Hold
17,446
– – ﹤0.01% 1397
2019
Q1 		$166K Hold
17,446
– – ﹤0.01% 1410
2018
Q4 		$200K Hold
17,446
– – 0.01% 1437
2018
Q3 		$296K Hold
17,446
– – 0.01% 1371
2018
Q2 		$248K Buy
17,446
+5,200
+42% +$86.4K 0.01% 1458
2018
Q1 		$233K Buy
12,246
+1,600
+15% +$34.2K 0.01% 1413
2017
Q4 		$175K Buy
+10,646
New +$158K ﹤0.01% 1286

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Xact Kapitalforvaltning's SGMO Position: Q1 2020 in Review

Xact Kapitalforvaltning held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2020 at 17,446 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1280.

Xact Kapitalforvaltning first reported a position in SGMO in Q4 2017 and has held it in 10 quarters since. The position peaked at $296K in Q3 2018. 190 funds tracked by Wall St. Rank hold SGMO as of Q1 2020.

  • Xact Kapitalforvaltning held 17,446 shares of SANGAMO THERAPEUTICS INC worth $111K as of Q1 2020.
  • Xact Kapitalforvaltning left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2020.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1280 holding.
  • Xact Kapitalforvaltning first reported a position in SANGAMO THERAPEUTICS INC in Q4 2017 and has held it in 10 quarters since.
  • Xact Kapitalforvaltning's SANGAMO THERAPEUTICS INC position peaked at $296K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.